Senior insider sale
Chief Financial Officer at WHITEHAWK THERAPEUTICS, INC. — senior position signals high conviction
$908.6K
236.36K shares
What this filing means
GIACOBELLO SCOTT M. plans to sell 236.36K shares of WHITEHAWK THERAPEUTICS, INC. valued at approximately $908.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/16/2026ACC: 0001754154-26-000007
Officer· Chief Financial Officer
Since Nov 2021
236.36K
Shares to sell
$908.6K
Approx. market value
473.90K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/1/2026
473.90KTotal acquired473.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Restricted Stock Units N/A | 473.90K | — |
| Total | 473.90K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.59K
Market value
$8.6K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
233.77K
Market value
$900.0K
4/15/2026
Total
Units
236.36K
Value
$908.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 2.59K | $8.6K | — | Completed |
| Planned — Approximate Date | ||||
4/15/2026 | 233.77K | $900.0K | NASDAQ | Planned |
| Total | 236.36K | $908.6K | ||